Blair, Tiffany
Baird, Jason
Bambina, Shelly
Kramer, Gwen
Gostissa, Monica
Harvey, Christopher J.
Gough, Michael J.
Crittenden, Marka R.
Funding for this research was provided by:
National Institutes of Health (NIH R01CA182311, NIH R01CA182311)
Jounce Therapeutics
Article History
Received: 19 January 2022
Accepted: 26 August 2022
First Online: 2 September 2022
Competing interests
: MR Crittenden reports research support from Jounce Therapeutics during the course of this study and also receives research funding from Bristol Myers Squibb and VIR that is not related to the subject of this manuscript. MJ Gough reports research support from Jounce Therapeutics during the course of this study and receives funding from Bristol Myers Squibb and VIR that is not related to the subject of this manuscript. M Gostissa is an employee and owns stock of Jounce Therapeutics. CJ. Harvey was an employee of Jounce Therapeutics during the time of study conduct. TB,JB,SB and GK have nothing to disclose and no conflicts of interest.